University of Texas's MD Anderson Cancer Center: Studies Reveal New Insights Into Gut Microbiome Impact on Immunotherapy Response in Multiple Cancers, Including Glioblastoma
June 07, 2022
June 07, 2022
HOUSTON, Texas, June 7 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following news release on June 6, 2022:
* * *
MD Anderson researchers present findings at 2022 ASCO Annual Meeting
* * *
Two studies led by The University of Texas MD Anderson Cancer Center that shed new light on the potential of the gut microbiome as a targetable biomarker to improve responses to immunotherapy were presented today at the 2022 . . .
* * *
MD Anderson researchers present findings at 2022 ASCO Annual Meeting
* * *
Two studies led by The University of Texas MD Anderson Cancer Center that shed new light on the potential of the gut microbiome as a targetable biomarker to improve responses to immunotherapy were presented today at the 2022 . . .